Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176318Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | López-Yerena, Anallely | - |
| dc.contributor.author | Vallverdú i Queralt, Anna | - |
| dc.contributor.author | Mols, Raf | - |
| dc.contributor.author | Augustijns, Patrick | - |
| dc.contributor.author | Lamuela Raventós, Rosa Ma. | - |
| dc.contributor.author | Escribano Ferrer, Elvira | - |
| dc.date.accessioned | 2021-04-15T09:14:09Z | - |
| dc.date.available | 2021-04-15T09:14:09Z | - |
| dc.date.issued | 2020-12-17 | - |
| dc.identifier.issn | 1999-4923 | - |
| dc.identifier.uri | http://hdl.handle.net/2445/176318 | - |
| dc.description.abstract | Recently, in February 2020, we published a study exploring the intestinal absorption and metabolism of oleocanthal (OLC) in rats. A single-pass intestinal perfusion technique (SPIP) was used, involving simultaneous sampling from the luminal perfusate and mesenteric blood. Later, comments on our published paper were released, requesting clarification of specific data. In this detailed reply, we hope to have addressed and clarified all the concerns of A. Kaddoumi and K. El Sayed and that the scientific community will benefit from both the study and the comments it has generated. | - |
| dc.format.extent | 8 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.publisher | MDPI | - |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics12121221 | - |
| dc.relation.ispartof | Pharmaceutics, 2020, vol. 12, num. 12, p. 1221 | - |
| dc.relation.uri | https://doi.org/10.3390/pharmaceutics12121221 | - |
| dc.rights | cc-by (c) López-Yerena, Anallely et al., 2020 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
| dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | - |
| dc.subject.classification | Biodisponibilitat | - |
| dc.subject.classification | Absorció intestinal | - |
| dc.subject.classification | Permeabilitat | - |
| dc.subject.other | Bioavailability | - |
| dc.subject.other | Intestinal absorption | - |
| dc.subject.other | Permeability | - |
| dc.title | Reply to 'Comment on López-Yerena et al. 'Absorption and intestinal metabolic profile of oleocanthal in rats' Pharmaceutics 2020, 12, 134' | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.identifier.idgrec | 707308 | - |
| dc.date.updated | 2021-04-15T09:14:09Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB)) Articles publicats en revistes (Institut de Recerca en Nutrició i Seguretat Alimentària (INSA·UB)) Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 707308.pdf | 979.46 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
